Xuan Zhang
Kunming University of Science and Technology(CN)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, Multiple Myeloma Research and Treatments
Most-Cited Works
- → A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity(2019)622 cited
- → Discovery of piperlongumine as a potential novel lead for the development of senolytic agents(2016)264 cited
- → Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity(2020)248 cited
- → PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics(2020)232 cited
- → A Biodegradable Low Molecular Weight Polyethylenimine Derivative as Low Toxicity and Efficient Gene Vector(2009)166 cited
- → Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,(2021)143 cited
- → A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population(2022)140 cited
- → Rice straw pretreatment using deep eutectic solvents with different constituents molar ratios: Biomass fractionation, polysaccharides enzymatic digestion and solvent reuse(2018)137 cited
- → DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas(2020)125 cited
- → WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA(2021)125 cited